Toxicology International (Formerly Indian Journal of Toxicology)

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Patients Treated with Antidepressants and the Relative Risk of Suicide Attempt


Affiliations
1 Toxicology Unit, Emergency Hospital, Mansoura University, Mansoura, Egypt
     

   Subscribe/Renew Journal


Tricyclic antidepressants (TCAs) have been approved by the Food and Drug Administration (FDA) specifically to treat depression, with their generic or chemical names. The aim of this study was to characterize patients on antidepressants after self-poisoning with suicidal intent regarding age, sex, type of current antidepressant therapy, and type of substances ingested in order to commit suicide. This study was conducted on patients (n=1283) of different ages, 924 males and 359 female. These patients were attended to poison unit at emergency hospital, Mansoura University during the period from January 2002 to December 2009. During the study period, 175-Para suicide patients were found with current antidepressants therapy and presented with self-poisoning using their antidepressant therapy or other medications. A substantial difference between different types of antidepressants was found. Para suicide risks for selective serotonin reuptake inhibitor were significantly low than those of tricyclic antidepressants, so in suicide prevention, risks and benefits of antidepressant should be taken into account when choosing treatment for depressive patients. At the same time, depressed patients should be under close psychiatric assessment in order to prevent such possible suicidal attempts.

Keywords

Blood Samples, Antidepressant Drug, EMIT.
User
Subscription Login to verify subscription
Notifications
Font Size

  • Altamura, C.; VanGastel, A.; Pioli, R.; Mannu, P. and Maes, M. Seasonal and circadian rhyms in suicide in Cagliari, Italy, Journal of Affective Disorders 1999; 53, 77-85.

  • American Psychiatric Association practice guideline for assessment and treatment of patients with suicidal behaviors. American Journal of psychiatry 60 (11 suppl.), 2003; 1-60.

  • Bertolote, J.M.; Fleishmann, A.; De Leo, D. and Wasserman, D. Suicide and mental disorders: do we know enough? British Journal of Psychiatry. 2003; 183, 382-383.

  • Billi-Brahe, U.; Kerkhof, A.; De Leo, D.; Schmidtke, A.; Crepet, P.; Lonnqvist, J.; Michel, K.; Salander-Renberg, E.; Stiles, T.C.; Wasserman, D.; Aagaard, B.; Egebo, H. and Jensen. B. A repetition-prediction study of European Para suicide populations: a summary of the first report from part II of the WHO /EURO multicoated study on Para suicide in co-operation with the EC concerted action on attempted suicide. Acta psychiatrica scandinavica. 1997; 95, 81-86.

  • De Hert, M.; Mckenzie, K. and Peuskens, J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophrenia Research. 2001; 47, 127-134.

  • Dieserud, G.; Loeb, M. and Ekeberg, O. Suicidal behavior in the municipality of Baerum, Norway: a 12- year prospective study of Para suicide and suicide. Suicide and life threatening behavior. 2000; 30, 61-73.

  • Fergusson, D.M.; Woodward, L.J. and Horwood, L.J. Risk factors and life processes associated with the onset of suicidal behavior during adolescence and early adulthood. Psychological Medicine. 2000; 30, 23-39.

  • Gokay, B.; Ercan, A.; Ibrahim, A.; Goksel, K.; Mevlut, T.; Fatma, O. S.; Sukru, P.; Kubra, T. and Cetin, A. “Clastogenicity of selective serotonin reuptake inhibitors mutations research”. Genetic Toxicology and Environmental Mutagenesis. 2004; 558, (1-2) 14:137-144.

  • Henry, J.; Alexander, C. and Sener, E. Relative mortality from overdose of antidepressants. Br. Med. J. 1995; 310, 221-224.

  • Hotopf, M.; hardy, R. and Lewis, G. Discontinuation rates of SSRIs and TCAs: a meta-analysis and investigation of heterogeneity. Br. J. Psychiatry. 1997; 170, 120-127.

  • Isacsson, G.; Holmgren, P.; Druid, H. and Bergman, U. The Utilization of antidepressants- a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweeden during the period 1992-1994. Acta. Psychiatr. Scand. 1997; 96, 94-100.

  • Kapur, S.; Mieczkowski, M. and Mann, J. Antidepressants medications and the relative risk of suicide attempt and suicide. J. Am. Med. Assoc. 1992; 268, 3441-3445.

  • Maris, R.W. Suicide. Lancet. 2002; 360, 319-326.

  • Montgomry, S. and Kasper, S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants. A meta-analysis. Int. Clin. Psychopharmacology. 1995; 4, 33-40.

  • Nordentoft, M. and Branner, J.: Gender differences in suicidal intent and choice of method among suicide attempters crisis.”The journal of crisis intervention and suicide prevention, 2008; 29 (4), 209 – 212.

  • Paykel, E. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression. Acta Pshyctri. Scand. 1995; 91 (suppl. 386), 22-27.

  • Rutz, W., Woalinger, J.; Von Knorring, L.; Rihmer, Z, and Pihlgren, H. Prevention of depression and suicide by education and medication: impact on male suicidailty. An update from the Gotland study. Int. J. Psychiatry Clin. Pract. 1997; 1, 39-46.

  • Simon, O.R.; swann, A.C.; Powell, K.E.; potter, L.B.; kresnow, M.J. and O’Carroll, P.W. Characteristics of impulsive suicide attempts and attempters. Suicide and life-threatening behavior. 2001; 32, 49-59.

  • Zisook,S; Trivedi, M.H; Warden, D; Lebowitz, B; Thase, M.E; Stewart, J.W; et.al: “ Clinical correlates of the worsening or emergence of suicide ideation during SSRI treatment of depression: An examination of citalopram in the STARD study”. Journal of affective disorders, 2009; 117(1-2), 63 – 73.


Abstract Views: 486

PDF Views: 12




  • Patients Treated with Antidepressants and the Relative Risk of Suicide Attempt

Abstract Views: 486  |  PDF Views: 12

Authors

R. A. Mandour
Toxicology Unit, Emergency Hospital, Mansoura University, Mansoura, Egypt

Abstract


Tricyclic antidepressants (TCAs) have been approved by the Food and Drug Administration (FDA) specifically to treat depression, with their generic or chemical names. The aim of this study was to characterize patients on antidepressants after self-poisoning with suicidal intent regarding age, sex, type of current antidepressant therapy, and type of substances ingested in order to commit suicide. This study was conducted on patients (n=1283) of different ages, 924 males and 359 female. These patients were attended to poison unit at emergency hospital, Mansoura University during the period from January 2002 to December 2009. During the study period, 175-Para suicide patients were found with current antidepressants therapy and presented with self-poisoning using their antidepressant therapy or other medications. A substantial difference between different types of antidepressants was found. Para suicide risks for selective serotonin reuptake inhibitor were significantly low than those of tricyclic antidepressants, so in suicide prevention, risks and benefits of antidepressant should be taken into account when choosing treatment for depressive patients. At the same time, depressed patients should be under close psychiatric assessment in order to prevent such possible suicidal attempts.

Keywords


Blood Samples, Antidepressant Drug, EMIT.

References





DOI: https://doi.org/10.22506/ti%2F2016%2Fv23%2Fi2%2F146686